BI
CBIO

BVF Inc’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$22.4M Sell
1,387,863
-8,156,399
-85% -$132M 0.8% 23
2025
Q1
$2M Hold
9,544,262
0.08% 46
2024
Q4
$2.38M Hold
9,544,262
0.08% 48
2024
Q3
$1.61M Hold
9,544,262
0.05% 49
2024
Q2
$2.69M Hold
9,544,262
0.08% 50
2024
Q1
$28.6M Hold
9,544,262
0.79% 31
2023
Q4
$22.5M Hold
9,544,262
0.56% 36
2023
Q3
$14.3M Hold
9,544,262
0.39% 38
2023
Q2
$16.6M Hold
9,544,262
0.46% 38
2023
Q1
$12M Hold
9,544,262
0.44% 46
2022
Q4
$28.9M Hold
9,544,262
1.22% 29
2022
Q3
$5.27M Hold
9,544,262
0.22% 60
2022
Q2
$5.71M Hold
9,544,262
0.28% 56
2022
Q1
$10.9M Hold
9,544,262
0.44% 55
2021
Q4
$13.7M Hold
9,544,262
0.5% 48
2021
Q3
$20.9M Hold
9,544,262
0.82% 35
2021
Q2
$22.1M Hold
9,544,262
0.83% 31
2021
Q1
$28.7M Hold
9,544,262
1.08% 25
2020
Q4
$35.9M Buy
9,544,262
+2,300,000
+32% +$8.65M 1.41% 26
2020
Q3
$22.2M Hold
7,244,262
1.21% 28
2020
Q2
$27.2M Sell
7,244,262
-117,539
-2% -$442K 1.68% 22
2020
Q1
$16.8M Hold
7,361,801
1.56% 20
2019
Q4
$38.9M Hold
7,361,801
2.95% 11
2019
Q3
$31.7M Buy
+7,361,801
New +$31.7M 3.33% 10
2018
Q1
Sell
-497,474
Closed -$8.35M 45
2017
Q4
$8.35M Sell
497,474
-2,732,382
-85% -$45.9M 1.01% 26
2017
Q3
$45.2M Buy
3,229,856
+259,674
+9% +$3.63M 5.74% 6
2017
Q2
$33.1M Buy
2,970,182
+143,900
+5% +$1.61M 5.15% 6
2017
Q1
$15.3M Hold
2,826,282
2.61% 13
2016
Q4
$17.2M Buy
2,826,282
+400,000
+16% +$2.44M 3.46% 10
2016
Q3
$17.3M Sell
2,426,282
-21,133
-0.9% -$151K 3.27% 11
2016
Q2
$17.8M Buy
+2,447,415
New +$17.8M 3.79% 9